A Revolution in
Eye Disease Treatment

ABOUT THE COMPANY
Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. Founded in 2011, the company has developed, and is now commercial with intelligently designed and engineered products that target the underlying causes of the world’s most prevalent eye diseases.
The company’s surgical glaucoma product portfolio features the OMNI™ Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and transluminal viscoelastic delivery. The company’s non-surgical Dry Eye product portfolio consists of TearCare® which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.
  • LEADERSHIP TEAM
  • BOARD OF DIRECTORS
grafic lines 4
Paul Badawi
FOUNDER & CHIEF EXECUTIVE OFFICER
Founder and Chief Executive Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Prior to launching Sight Sciences, Paul led the U.S. healthcare venture capital practice for 3i Group, a global private equity firm.

At 3i, Paul managed a portfolio of 12 medical device investments and $120MM invested. He served as a lead investor and board member for Ulthera (acquired by Merz), Xthetix (acquired by J&J), NeoGuide (acquired by Intuitive Surgical), OmniGuide, and Sotera Wireless, and as an observer on the boards of Small Bone Innovations (acquired by Stryker), Zonare (acquired by Mindray), and Transmedics. Prior to entering the medical device world, Paul worked at the National Institutes of Health as a Research Fellow in the biochemical genetics laboratory of a Nobel Prize-winning scientist credited with cracking the genetic code. Paul received a BS in Biological Sciences from the University of Chicago, an MBA from UCLA, and is a graduate of the Kauffman Fellows Program.

read more read less
Dr. David Badawi, MD
FOUNDER & CHIEF TECHNOLOGY OFFICER
Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™Microstent, and TearCare®.
David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease.

He also oversees the preclinical and clinical development of each of the company’s products. In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs. David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.

read more read less
Jesse Selnick
CHIEF FINANCIAL OFFICER
Chief Financial Officer of Sight Sciences, Inc. He brings to Sight Sciences more than 20 years of experience leading strategic growth, financing, capital allocation and operational initiatives for growing technology companies.
Most recently, Jesse served as Chief Financial Officer and on the Board of Directors of Electric Lightwave, an over $500 million revenue, private equity sponsored telecom infrastructure business, prior to its acquisition for $1.4B in 2017.

At Electric Lightwave, Jesse led an approximately 100-person team responsible for corporate strategy, M&A, capital planning, treasury, accounting and tax, financial planning and analysis, business development, real estate and risk management. Earlier in his career, Jesse served as a Managing Director at The Blackstone Group for approximately 10 years in its mergers and acquisitions advisory practice. He holds a BS in Economics from The Wharton School at The University of Pennsylvania and an MBA from Harvard Business School.

read more read less
Shawn O’Neil
CHIEF COMMERCIAL OFFICER
An ophthalmic industry veteran who leads Sight Sciences’ commercial activities and product launches.
Previously, Shawn spent more than 20 years at Alcon, a global leader in eye care, where he covered both Ophthalmology and Optometry.

During his tenure at Alcon, he was responsible for developing commercial teams and strategies to launch novel and disruptive technologies including the Opti-Free RepleniSH Multi-Purpose Solution, EX-PRESS Glaucoma Filtration Device, LenSx Laser System, and CyPass Micro-Stent for glaucoma. Shawn earned a bachelor’s degree in Economics from Princeton University.

read more read less
Dr. Reay H. Brown, MD
CHIEF MEDICAL OFFICER
Chief Medical Officer (CMO) of Sight Sciences, Inc. In his role as CMO, Dr. Brown works closely with the Company's research and development team on making improvements to existing products and on new product innovation, as well as with Sight Sciences' clinical and commercial teams.
Reay H. Brown, M.D. is a board certified ophthalmologist specializing in glaucoma and cataract surgery with intraocular lens implantation.

He has been in practice in Atlanta since 1988. Dr. Brown has published more than 90 peer reviewed articles on glaucoma and cataract surgery. He has served as chairman of the ASCRS Glaucoma Committee and is currently the Glaucoma Editor of EyeWorld magazine. He recently received the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Brown is one of only a few ophthalmologists in Georgia to receive this prestigious award. He received the 2013 Distinguished Alumnus Award from John Hopkins University (Wilmer Eye Institute) and the 2014 Innovator Award form the American Glaucoma Society. He has given many named lectures all over the world including the Obstbaum Lecture at the 2011 ASCRS Glaucoma Day. He was selected to give the Charles D. Kelman Innovator Lecture in 2017. This international award honors Dr. Kelman, the inventor of phacoemulsification, a huge step forward in successful cataract surgery outcomes. This award has only been given to 33 innovators in eye surgery since its inception in 1985.

Dr. Brown and his wife, Dr. Mary G. Lynch, a Professor at Emory, have been awarded 25 patents for new devices and instruments to improve glaucoma and cataract surgery. Their patents on trabecular bypass are the fundamental patents for several innovative devices implanted into the outflow channel of the eye. Dr. Brown has been selected by his peers to be listed each year in Best Doctors in America and by a separate peer survey in Atlanta Magazine as one of the best ophthalmologist in Atlanta.

Dr. Brown earned his undergraduate degree from Harvard College Cum laude and completed medical school at the University of Michigan. He trained in ophthalmology at the Wilmer Eye Institute of Johns Hopkins University. He then completed a glaucoma fellowship at the Bascom Palmer Eye Institute and returned to Johns Hopkins as Chief Resident.

Dr. Brown was selected as the first Pamela Firman Professor of Ophthalmology at the Emory Eye Center. Mrs. Firman made the donation for the professorship in gratitude for Dr. Brown’s care of her eyes. He served as the Director of the Glaucoma Service at Emory for eleven years prior to entering private practice with Atlanta Ophthalmology Associates in 1999.

Drs. Brown and Lynch have two daughters, Veronica and Annie. Rounding out their household is, Lily, a loving English Mastiff. Dr. Brown is an avid runner, enjoys playing tennis and traveling with his family.

read more read less
Aaron Capsel
VICE PRESIDENT OF SALES AND BUSINESS OPERATIONS
Leads the business and sales operations efforts for Sight Sciences. He brings more than 20 years of experience across the technology sector enabling teams in wide variety of finance, sales, and operational roles.
Prior to joining Sight Sciences, Aaron served as Regional CFO for Zayo Group’s western region technology network infrastructure business segment, leading the team responsible for financial performance, strategic initiatives, and capital planning.

Before this, Aaron was senior vice president for Electric Lightwave, a private equity backed telecom infrastructure business, where he spent nearly 10 years and held numerous leadership roles, spanning from sales operations and business intelligence to corporate strategy and investor relations.

He holds a BS in Finance from University of Illinois at Urbana-Champaign and an MBA from The Keller Graduate School of Management.

read more read less
Jeff Francis
VICE PRESIDENT OF SALES, SURGICAL GLAUCOMA
Responsible for leading the sales force for Sight Sciences’ surgical devices. Jeff has nearly 20 years of experience in the pharmaceutical, medical device and surgical arenas.
Before joining Sight Sciences, Jeff was an associate regional sales director at Nestle Skin Health, a global leader in skin health and wellness.

Prior, Jeff held positions of increasing responsibility in sales training, sales leadership, marketing and hospital/corporate accounts at Alcon Laboratories, where he began his career. Jeff brings to Sight Sciences a passion and commitment for building, developing and empowering high performing sales teams. Jeff holds a bachelor’s degree from the University of Kansas.

read more read less
Rob Hill
VICE PRESIDENT OF INTERNATIONAL SALES
Rob has 25 years experience of successfully launching innovative and disruptive ophthalmic technology in OUS markets with a strong background in product distribution and international sales.

Prior to joining Sight, Rob has held international sales leadership, managing director and CEO roles with multiple multi-national organizations such as IntraLase, Malosa Medical, Calhoun Vision and most recently Avedro. Rob has built a strong personal and professional network of global Key Opinion Leaders and commercial partners while building and managing commercial infrastructure that contributed to the creation of world leading markets for multiple innovation driven enterprises.

Rob brings an extensive amount of leadership and business acumen, specifically in the global markets, to the Sight Sciences leadership team. Rob holds a degree in Business Administration & Finance from Coventry University, UK.

read more read less
Jessica Holmes
VICE PRESIDENT OF HEALTH POLICY & REIMBURSEMENT
Leads Health Policy & Reimbursement efforts for Sight Sciences. Jessica brings more than 25 years of experience in payer- and provider-relations, government affairs, reimbursement strategy, tactical planning and execution.
Jessica has created and executed reimbursement/market access strategies both as a leader within operating companies and as a consultant to commercialize novel technologies in the areas of medical device, biotechnology, diagnostics, combination products, capital equipment and durable medical equipment.

Previously, Jessica directed the prominent medical device reimbursement and market access practice at Navigant Consulting as Director of Life Sciences and served as Vice President of Reimbursement for Argenta Advisors, Inc. She will be leading the reimbursement and health policy strategy for all of the Company’s Surgical and Dry Eye portfolio, ensuring the technologies are accessible to both health care professionals and their patients.

Jessica earned a bachelor’s degree from the University of California at Berkeley and a Master of Jurisprudence in Health Law from Loyola University Chicago School of Law.

read more read less
Ingrid Kane, MD
VICE PRESIDENT OF GLOBAL MEDICAL AFFAIRS
An ophthalmologist who, over the past twenty years, has demonstrated great success working with ophthalmic medical device companies in all stages of product development, clinical trial research, and commercialization. Before joining Sight Sciences, Ingrid spent a decade introducing an interventional surgical glaucoma procedure to surgeons in 25 countries around the world.
As Vice President of Medical Affairs at iScience Interventional and later at Ellex, Ingrid provided hundreds of didactics, wet labs, and hands-on surgical evaluations around the world for ab externo canaloplasty – one of the most technically challenging procedures in ophthalmology

Through her deep knowledge of ophthalmic physiology and disease and her personal approach to clinical training, Ingrid has formed very strong relationships and gained the trust of ophthalmic surgeons around the globe. Ingrid is applying this same level of clinical excellence and personalized training as she introduces Sight Sciences products and procedures to surgeons worldwide.Ingrid began her career in the ophthalmic industry after moving to the United States and joining Oculex Pharmaceuticals (ultimately acquired by Allergan). At Oculex, Ingrid was instrumental in the development of a commercially successful ophthalmic drug delivery systems and is a patent holder on Ozurdex, an intravitreal implant for the treatment of macular edema, diabetic macular edema, and uveitis. Ingrid earned her medical degree at Charles University in Prague, Czech Republic and completed her ophthalmology training at the First Eye Clinic at Charles University.

read more read less
Todd Love
VICE PRESIDENT OF SALES, DRY EYE
Responsible for leading the sales force for Sight Sciences’ dry eye portfolio.
He has extensive experience in the optometric industry spanning nearly 20 years in a variety of sales, marketing, and professional development leadership roles in which he consistently increased company value, delivered business results and successfully launched major global brands.

Todd joined Sight Sciences from Bausch + Lomb where he was Director, Professional Strategy and led the development of key opinion leaders, optometric institutions and professional programs. Prior, Todd held positions of increasing responsibility at Alcon Laboratories in sales, sales leadership, market development, global marketing and brand management where he led the company’s global contact lens care franchise. During his tenure at Alcon, he was awarded PM360’s Trailblazer Award for Industry Wide Marketing Innovation. Todd holds a bachelor’s degree in business administration from the University of Houston.

read more read less
Daniel O'Keeffe
VICE PRESIDENT OF RESEARCH & DEVELOPMENT
Co-inventor of the OMNI®Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Daniel has been instrumental in the successful growth and development of Sight Sciences since the company’s earliest days.

Prior to joining Sight Sciences and entering the world of ophthalmology, Daniel amassed over ten years of successful research and development product development experience in cardiovascular catheters, vascular surgery delivery systems and surgical instruments. Daniel has designed and developed innovative products for industry leaders such as Boston Scientific and smaller start-ups such as Aptus Endosystems. Daniel received a BS in Mechanical Engineering from the California Polytechnic State University, San Luis Obispo.

read more read less
John Ordway
VICE PRESIDENT OF GLOBAL SUPPLY CHAIN
Leads the manufacturing and operational efforts for Sight Sciences. John has over 25 years of experience in medical device manufacturing, supply chain, and operations management.
Prior to joining Sight Sciences, John was the Vice President of Operations for Moximed, a venture-backed orthopedic medical device company.

Previously, he held senior positions managing supply chain, supplier quality, incoming inspection, manufacturing, and global distribution for commercially successful venture-backed start-ups including Angioscore (acquired by Spectranetics), St. Francis Medical (acquired by Kyphon/Medtronic), and Surgical Dynamics (acquired by Stryker). John began his career in manufacturing and supply chain management at Guidant. Prior to entering the world of ophthalmology, John consistently helped develop and transition a variety of innovative medical devices in both orthopedics (knee implants, spinal fusion, discectomy, spinal stenosis) and cardiovascular (scoring balloon catheters, saphenous vein harvesting systems, and minimally invasive devices for general surgery) to full scale manufacturing. John holds an MBA from Thunderbird School of Global Management and a BS in Political Science and Psychology from the University of Oregon.

read more read less
Sam Park
CHIEF OPERATING OFFICER
Sam has more than 25 years of medical device start-up experience in design and operations building pre-revenue companies, and leading them through to acquisition.
Prior to joining Sight Sciences Inc., Sam served as VP of R&D and Operations at SurgRx where he led the development of EnSeal Vessel Sealing System which was purchased by Ethicon-Endo Surgery of J&J.

He also led operations at Novacept from early revenue to its acquisition by Cytyc. Sam has held various other executive and technical positions at Spineview (Expending Innovation), Arthrocare (acquired by Smith and Nephew), CardioGenesis (IPO), and Origin Medsystems (acquired by Eli Lily, later Guidant).

Before entering the medical device industry, Sam worked in aerospace at Hughes Aircraft, and Xerox Designing and Manufacturing Laser Systems.
Sam hold a BS from the University of California Irvine in Mechanical Engineering.

read more read less
Chris Pike
VICE PRESIDENT OF IT
Leads the IT group for Sight Sciences’. Before joining Sight Sciences, Chris was Vice President of IT and CIO at Allstream, a North American telecommunications and connectivity provider with responsibilities for the network architecture, technology innovation and network operations teams.
As Vice President, Information Technology, Chris Pike leads Sight Sciences IT.

Chris has more than 20 years’ experience driving IT, Security, Process, and Operational improvement programs. He is a strategic innovator adept at defining, designing and commercializing leading edge technologies. He has a degree in IT and Finance from Oregon State University.

read more read less
Brian Regan
Vice President of Strategy and Professional Relations
Brian Regan is a highly experienced healthcare operating executive with senior leadership roles focused in marketing, sales and business development at a number of leading medical technology and consumer product companies.
Prior to joining Sight Sciences, Regan was Vice President of Marketing & Development at Johnson & Johnson Vision following its acquisition of TearScience, Inc.

Regan was an executive committee member and marketing organization leader during his more than 10 years with TearScience, and through this work, is considered one of the thought leaders in the development of the evaporative dry eye market. Regan will be leveraging his broad industry experience to lead strategy across both the Surgical and Dry Eye businesses, with a focus on the company’s interactions with key opinion leaders within the Ophthalmology and Optometry specialties.

read more read less
Stacie Rodgers
VICE PRESIDENT OF HR
Stacie Rodgers leads the Human Resources team for Sight Sciences. Stacie brings over 20 years of HR leadership experience in the medical device space.

Stacie has been instrumental in leading HR for start-up companies including Cutera and helping to manage their growth from 5 to 220 employees and an eventual IPO. Stacie has also worked in the eyecare medical device space leading HR functions for Iridex.

read more read less
Edward Sinclair
VICE PRESIDENT OF REGULATORY AFFAIRS
Ed Sinclair Leads the Regulatory Affairs effort for Sight Sciences.
Ed bring over 30 years of experience with experience in all aspects of international and domestic regulatory affairs, quality, clinical, metrology and compliance.

Ed has developed and executed regulatory strategies for a variety of companies, from start-ups to growth stage companies within the medical device field and specifically within ophthalmology.

Prior to joining Sight Sciences, Ed was Vice President, Regulatory and Quality Affairs at Iridex, Optovue, Inc., and Asante Solutions, Inc. He was also Vice-President, Clinical/Medical & Regulatory/Quality Affairs and Chief Compliance Officer at Baxano Inc. in San Jose, CA.

Ed holds a B.S. Biological Sciences, University of California, Irvine and an M.A., Management, University of Redlands.

read more read less
Jim Sluck
VICE PRESIDENT OF MARKETING, DRY EYE
Leads dry eye marketing efforts at Sight Sciences’ for TearCare , previously Jim held similar commercial leadership positions at Galderma (skincare division of Nestle) and Alcon.
Jim Sluck brings nearly 30 years of medical industry strategy development and commercial execution to Sight Sciences.

During his 23 year tenure at Alcon, he held escalating positions of leadership in sales, managed markets, domestic marketing, global marketing and finally Head of U.S. Pharmaceutical Marketing before moving to the global leader in dermatology, Galderma, as Vice President of U.S. Prescription marketing.

Jim earned his bachelor’s degree from the University of Pittsburgh.

read more read less
Patrick Smale
VICE PRESIDENT OF MARKETING, SURGICAL GLAUCOMA
Leads the marketing program for Sight Sciences’ surgical portfolio. Before joining Sight Sciences, Patrick was Global Product Director, Surgical Glaucoma at Alcon Laboratories where he was responsible for the global launch of the CyPass Micro-stent.
In this role, Patrick led the market analytics and assessment, campaign development and lifecycle management activities for Alcon’s surgical glaucoma portfolio.

Prior, he held positions of increasing responsibility and leadership in market research and business analytics covering the pharmaceutical, surgical and vision care businesses. Patrick holds a bachelor’s degree in kinesiology and biology from Occidental College and an MBA from the University of Delaware, Lerner College of Business and Economics.

read more read less
Dr. David Badawi, MD
FOUNDER & CHIEF TECHNOLOGY OFFICER
Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™Microstent, and TearCare®.
David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease. He also oversees the preclinical and clinical development of each of the company’s products.

In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs.

David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.

read more read less
Paul Badawi
FOUNDER & CHIEF EXECUTIVE OFFICER
Founder and Chief Executive Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Prior to launching Sight Sciences, Paul led the U.S. healthcare venture capital practice for 3i Group, a global private equity firm.

At 3i, Paul managed a portfolio of 12 medical device investments and $120MM invested. He served as a lead investor and board member for Ulthera (acquired by Merz), Xthetix (acquired by J&J), NeoGuide (acquired by Intuitive Surgical), OmniGuide, and Sotera Wireless, and as an observer on the boards of Small Bone Innovations (acquired by Stryker), Zonare (acquired by Mindray), and Transmedics. Prior to entering the medical device world, Paul worked at the National Institutes of Health as a Research Fellow in the biochemical genetics laboratory of a Nobel Prize-winning scientist credited with cracking the genetic code. Paul received a BS in Biological Sciences from the University of Chicago, an MBA from UCLA, and is a graduate of the Kauffman Fellows Program.

read more read less
Staffan Encrantz
ALLEGRO INVESTMENT FUND, L.P.
Founder and Chairman of Allegro Investment Fund, L.P., a registered Cayman Islands Investment Fund that is managed by Allegro Investment Inc. Located in Menlo Park, CA, Allegro primarily invests in growth stage private companies and supports its portfolio by providing growth capital as well as strategic, operating and financial expertise.
Mr. Encrantz has actively led investments in and operation of a variety of companies for over 30 years. He has led the growth and development of both early stage companies and established businesses in a wide variety of fields.

Mr. Encrantz is currently Chairman of AnaMar AB, ClosingCorp Inc, Evolve Controls, LLC, Nclear Inc, Alestra Ltd., Koncentra Holding AB and the Koncentra Verkstads AB group. He is also a director of GovX, Inc, Oxymetal SAS and several other companies.

Mr. Encrantz previously worked at ASEA AB, Sweden (now ABB Ltd.), as its deputy General Counsel 1979-1981, as Finance Manager 1981-1984, and during 1984-1990 in Switzerland and the UK as Business Area manager responsible for ABB’s Commodity Trading and Counter Trading group. Prior to this, he worked at Skandia Insurance Co, Sweden as its General Counsel and in private law practice.

Mr. Encrantz holds a law degree (Magna cum Laude) from Uppsala University, Sweden.

read more read less
Mack Hicks
HICKS HOLDINGS, LLC
Partner of Hicks Holdings, LLC, and has been with the firm since 2007. In addition to his involvement with Hicks Holdings, he served as the Managing Partner of Hicks Cedar Park LLC from 2008 to 2014, which owned and operated the Cedar Park Center and the Texas Stars AHL hockey franchise.
Mr. Hicks is also Co-Founder of Golfswing.com, an Internet marketing company focused on online golf instruction.

Prior to his involvement with Hicks Holdings, Hicks served as a research analyst at Halcyon Asset Management LLC from 2006 to 2007. Halcyon is a multi-strategy investment firm with $14 billion of AUM, where he was involved in investments in fixed income securities and in public and private equity transactions.

From 2004 to 2006, he served as an analyst in the Financial Sponsors Group of Credit Suisse, an investment banking firm. As an analyst at Credit Suisse, Hicks was involved with several leveraged buyouts, recapitalizations and acquisitions.

Mack received a BA degree from the University of Texas at Austin in 2003, and is currently enrolled in the Owner / President Management Program at Harvard Business School. Hicks is also a member of the North Texas Chapter of YPO. He currently resides in Dallas, Texas, with his wife and daughter.

read more read less
Carter Meyer
SCIENTIFIC HEALTH DEVELOPMENT
Chief Executive Officer of Scientific Health Development (SHD) since its formation in February 2006, and is a general partner of its newest fund. Located in Dallas, Texas, SHD is an investment fund focused on earlier-stage life science companies.
Prior to joining SHD, Mr. Meyer was an attorney in private practice for more than 12 years, most recently with the Dallas office of Vinson & Elkins L.L.P.

Carter has a BBA in finance from Texas Christian University and a JD from St. Mary’s University School of Law. Mr. Meyer is a director of all SHD portfolio companies.

read more read less
Erica Rogers
SILK ROAD MEDICAL
President and CEO of Silk Road Medical (NASDAQ: SILK), is an experienced leader and entrepreneur in the medical device industry.
She most recently led Silk Road Medical through FDA approval of its groundbreaking TCAR devices for the treatment of carotid artery disease, commercial scale-up and initial public offering.

Prior to her role at Silk Road Medical, Ms. Rogers was the Chief Operating Officer of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women. She was previously the founder and CEO of Allux Medical, as well as the co-founder of Visiogen, an ophthalmic medical device company acquired by Abbott Medical Optics in 2009. In addition, Ms. Rogers is an advisor to Alydia Health, a company developing solutions for postpartum hemorrhage, and to Venture Investors, one of the leading healthcare venture capital firms based in the mid-western United States.
Erica holds five issued and 15 pending U.S. patents in medical devices and nanotechnology.

read more read less
Valeska Schroeder
KCK MEDICAL TECHNOLOGIES
Managing Director of KCK’s Medical Technologies Investment Group since 2016.
KCK is a single-family fund investing in a range of industries in private equity, growth capital, and venture capital, including a focus of growth equity investments in medical technology companies.

Valeska is a board member for KCK portfolio companies, including Sight Sciences, Cerapedics, Intuity Medical, and Aerin Medical and is a board observer for Reflexion Medical. Before joining KCK, Valeska held roles in product development, program management, and marketing in medical device companies, including VitalConnect, Acclarent, and NDC.
Valeska obtained a BS, MS, and PhD from University of California at Berkeley in Materials Science and Engineering.

read more read less
Don Zurbay
PATTERSON COMPANIES
Chief Financial Officer of Patterson Companies (NASD: PDCO) is an experienced financial and operational leader with a consistent track record of developing strategy and driving execution for business growth and expansion while optimizing operational efficiency.

He joined Patterson in June 2018 as Chief Financial Officer and has more than 28 years of experience in accounting and finance. Prior to joining Patterson, he served as Vice President and Chief Financial Officer at leading global medical device manufacturer St. Jude Medical, Inc., where he was responsible for all accounting, financial and business development activities prior to the company’s sale to Abbott in 2017 for approximately $25 billion.

Don is a current director of Silk Road Medical (NASD: SILK) and was a board member of Avedro, Inc. prior to its sale to Glaukos in late 2019. Don also previously held positions at PricewaterhouseCoopers, The Valspar Corporation, and Deloitte & Touche.

Don earned a Bachelor of Science degree in business accounting from the University of Minnesota and participated in the Advanced Management Program at Harvard Business School.

read more read less
grafic lines 4

Careers at Sight Sciences

For information on current job openings, please contact us at E: jobs@sightsciences.com
At Sight Sciences you’ll have the opportunity to join a team dedicated to revolutionizing the way the ophthalmic and optometric communities think about and treat the leading causes of eye disease. We are seeking candidates with a passion for delivering novel, game-changing technologies and who are committed to improving patient outcomes. Sight Sciences will process your personal information as described in this Privacy Statement and will be responsible for complying with applicable data protection laws. We respect your privacy and will treat your personal information as confidential. We will use and share your personal information as described in this Privacy Statement.
Download Privacy Notice for Job Applicants PDF